Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
McKinsey
Cipla
Cantor Fitzgerald
McKesson
Mallinckrodt

Generated: March 21, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Danirixin

« Back to Dashboard

US Patents for Danirixin

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Danirixin ➤ Sign Up IL-8 receptor antagonists GlaxoSmithKline, LLC (Philadelphia, PA) ➤ Sign Up
Danirixin ➤ Sign Up Hydrobromide salt of N-(4-chloro-2-hydroxy-3-((3S)-3-piperidinylsulfonyl)phenyl-N'-(3-fluoro-2- -methylphenyl)urea GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) ➤ Sign Up
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Danirixin

Drugname Country Document Number Estimated Expiration Related US Patent
Danirixin Argentina 060562 2026-04-21 ➤ Sign Up
Danirixin Australia 2007240365 2026-04-21 ➤ Sign Up
Danirixin Brazil PI0710232 2026-04-21 ➤ Sign Up
Danirixin Canada 2650009 2026-04-21 ➤ Sign Up
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Farmers Insurance
Healthtrust
Johnson and Johnson
Daiichi Sankyo
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.